Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments

Pharmaceutical Biology

Volumn 54, Issue 10, 2016, Pages 1947-1953

  Mansouri, Mohammad Taghi ^a   Farbood, Yaghoub ^a   Naghizadeh, Bahareh ^a   Shabani, Sohreh ^a   Mirshekar, Mohammad Ali ^b   Sarkaki, Alireza ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Elevated plus maze; memory deficit; passive avoidance

Indexed keywords

ELLAGIC ACID; DIAZEPAM; NOOTROPIC AGENT; SCOPOLAMINE BROMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIAZEPAM-INDUCED COGNITIVE DEFECT; ELEVATED PLUS MAZE TEST; EXPERIMENTAL COGNITIVE DEFECT; EXPERIMENTAL TRAUMATIC BRAIN INJURY; EXPLORATORY BEHAVIOR; LATENT PERIOD; LOCOMOTION; LONG TERM POTENTIATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; PHYTOCHEMISTRY; RAT; SCOPOLAMINE-INDUCED AMNESIA; SCOPOLAMINE-INDUCED COGNITIVE DEFECT; AMNESIA; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; LONG TERM MEMORY; MAZE TEST; MOTOR ACTIVITY; PSYCHOLOGY; WISTAR RAT;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; COGNITION; COGNITION DISORDERS; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; NOOTROPIC AGENTS; RATS, WISTAR; RETENTION (PSYCHOLOGY); SCOPOLAMINE HYDROBROMIDE;

EID: 84958045702     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1137601     Document Type: Article

References (33)

1. A.Blokland 1995. Acetylcholine:a neurotransmitter for learning and memory? Brain Res Rev. 21:285–300.
2. G.H.Buniatian 2003. Stages of activation of hepatic stellate cells:effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture. Cell Prolif. 36:307–319.
3. Y.H.Choi, G.H.Yan 2009. Ellagic acid attenuates immunoglobulin E-mediated allergic response in mast cells. Biol Pharm Bull. 32:1118–1121.
4. M.Dolatshahi, Y.Farbood, A.Sarkaki, M.T.Mansouri, A.Khodadadi. 2015. Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson's disease. Iran J Basic Med Sci. 18:38–46.
5. Y.Farbood, A.Sarkaki, M.Dianat, A.Khodadadi, M.Khaksari Haddad, S.Mashhadizadeh. 2015. Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury. Life Sci. 124:120–127.
6. Y.Feng, S.Yang, X.Du, X.Zhang, X.Sun, M.Zhao, G.Y.Sun, R.T.Liu. 2009. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun. 390:1250–1254.
7. F.Festa, T.Aglitti, G.Duranti, R.Ricordy, P.Perticone, R.Cozzi. 2001. Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res. 21:3903–3908.
8. N.Gacar, O.Mutlu, T.Utkan, I.Komsuoglu Celikyurt, S.Selcen Gocmez, G.Ulak. 2011. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacol Biochem Behav. 99:316–323.
9. C.Girish, V.Raj, J.Arya, S.Balakrishnan. 2012. Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. Eur J Pharmacol. 682:118–125.
10. C.Girish, V.Raj, J.Arya, S.Balakrishnan. 2013. Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice. Eur J Pharmacol. 710:49–58.
11. R.E.Hartman, A.Shah, A.M.Fagan, K.E.Schwetye, M.Parsadanian, M.Beth Finn, D.M.Holtzman. 2006. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 24:506–515.
12. E.A.Hassoun, J.Vodhanel, A.Abushaban 2004. The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol. 18:196–203.
13. B.Hunter, S.F.Zornetzer, M.E.Jarvik, J.L.McGaugh. 1988. Modulation of learning and memory:effects of drugs influencing neurotransmitters. In:L.L.Iversen, editors. Handbook of psychopharmacology. New York:Plenum Press. p. 531–577.
14. J.Itoh, T.Nabeshima, T.Kameyama 1991. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol. 194:71–76.
15. S.D.Iversen 1997. Behavioural evaluation of cholinergic drugs. Life Sci. 60:1145–1152.
16. S.Karlsson, E.Nanberg, C.Fjaeraa, J.Wijkander. 2010. Ellagic acid inhibits lipopolysaccharide induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr. 103:1102–1109.
17. D.H.Kim, S.J.Jeon, J.W.Jung, S.Lee, B.H.Yoon, B.Y.Shin, K.H.Son, J.H.Cheong, Y.S.Kim, S.S.Kang, et al. 2007. Tanshinone congeners improve memory impairments induced by scopolamine on passive avoidance tasks in mice. Eur J Pharmacol. 574:140–147.
18. R.G.Lister 1985. The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev. 9:87–94.
19. Q.S.Liu, Z.R.Pang, R.Liu, G.R.He, J.Cui, X.Y.Yin. 2011. Effective compounds group of Mongolian prescriptions BAIMAI-SAN protect against peripheral neuropathy in lower limbs of rats through neuroprotective effect. J Ethnopharmacol. 135:786–791.
20. S.Majid, K.L.Khanduja, R.K.Gandhi, S.Kapur, R.R.Sharma. 1991. Influence of ellagic acid on antioxidant defence system and lipid peroxidation in mice. Biochem Pharmacol. 42:1440–1445.
21. M.T.Mansouri, B.Naghizadeh, B.Ghorbanzadeh 2014. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test. Pharmacol Biochem Behav. 120:43–49.
22. M.T.Mansouri, B.Naghizadeh, B.Ghorbanzadeh, Y.Farbood. 2013. Central and peripheral antinociceptive effects of ellagic acid in different animal models of pain. Eur J Pharmacol. 707:46–53.
23. M.T.Mansouri, Y.Farbood, M.J.Sameri, A.R.Sarkaki, B.Naghizadeh, M.Rafeirad. 2013. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 138:1028–1033.
24. S.J.Park, D.H.Kim, J.M.Jung, J.M.Kim, M.Cai, X.Liu, J.G.Hong, K.R.Lee, J.H.Ryu. 2012. The ameliorating effects of stigmasterol on scopolamine-induced memory impairments in mice. Eur J Pharmacol. 676:64–70.
25. S.Pavlica, R.Gebhardt 2005. Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Radic Res. 39:1377–1390.
26. M.Rafieirad, K.Ghasemzadeh-Dehkordi 2014. Effect of ellagic acid on oxidative stress due to brain ischemia/hypoperfusion in male rat. J Herb Drugs. 5:1–6.
27. D.S.Reddy, S.K.Kulkarni 1998. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging-and dizocilpine-induced learning impairment. Brain Res. 799:215–229.
28. K.H.Reeta, J.Mehla, Y.K.Gupta 2009. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res. 1301:52–60.
29. S.Sellappan, C.C.Akoh, G.Krewer 2002. Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J Agric Food Chem. 50:2432–2438.
30. J.P.E.Spencer 2010. The impact of fruit flavonoids on memory and cognition. Br J Nutr. 104:40–47.
31. M.H.Thiebot 1985. Some evidence for amnesic-like effects of benzodiazepines in animals. Neurosci Biobehav Rev. 9:95–100.
32. D.M.Townsend, K.D.Tew 2003. The role of glutathione-S-transferase in anticancer drug resistance. Oncogene 22:7369–7375.
33. E.Uzar, H.Alp, M.U.Cevik, U.Firat, O.Evliyaoglu, A.Tufek, Y.Altun. 2012. Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci. 33:567–574.